Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2,075.00p
   
  • Change Today:
      75.00p
  • 52 Week High: 2,200.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 10,640
  • Market Cap: £108.42m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

Key Personnel

CEO: Peter John Harrison
CFO: Bruce Hiscock
Chairman: Ian James Nicholson
Independent Non-Executive Director: Nicholas (Nick) John McCooke
Independent Non-Executive Director: Joanne (Jo) Pisani
Independent Non-Executive Director: Chris Yates
Non-Executive Dir:

Contact Details

Address: 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Website: http://www.bioventix.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B4QVDF07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,075.00p
Change Today 75.00p
% Change 3.75 %
52 Week High 2,200.00
52 Week Low 1,366.67
Volume 10,640
Shares Issued 5.22m
Market Cap £108.42m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
81.37% below the market average81.37% below the market average81.37% below the market average81.37% below the market average81.37% below the market average
85.37% below the sector average85.37% below the sector average85.37% below the sector average85.37% below the sector average85.37% below the sector average
Price Trend
92.1% below the market average92.1% below the market average92.1% below the market average92.1% below the market average92.1% below the market average
67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average
Income Not Available
Growth
65.63% below the market average65.63% below the market average65.63% below the market average65.63% below the market average65.63% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Bioventix Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 05-Nov-26 09-Apr-26
Paid 20-Nov-26 24-Apr-26
Amount 80.00p 70.00p

Trades for 02-Nov-2026

Time Volume / Share Price
14:19 250 @ 2,007.10p
14:03 1 @ 2,100.00p
14:03 1 @ 2,100.00p
13:44 29 @ 2,035.00p
13:20 25 @ 2,007.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page